D. Guyader

977 total citations
13 papers, 644 citations indexed

About

D. Guyader is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, D. Guyader has authored 13 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 8 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in D. Guyader's work include Hepatitis C virus research (8 papers), Liver Disease Diagnosis and Treatment (5 papers) and HIV/AIDS drug development and treatment (4 papers). D. Guyader is often cited by papers focused on Hepatitis C virus research (8 papers), Liver Disease Diagnosis and Treatment (5 papers) and HIV/AIDS drug development and treatment (4 papers). D. Guyader collaborates with scholars based in France, United States and Germany. D. Guyader's co-authors include Romain Moirand, Pierre Brissot, Bruno Turlin, Yves Deugnier, Thierry Sapey, Véronique David, Michel-Henry Mendler, Jean‐Yves Le Gall, Olivier Loréal and Hervé Jouanolle and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and European Journal of Gastroenterology & Hepatology.

In The Last Decade

D. Guyader

13 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Guyader France 6 340 315 234 198 168 13 644
Hervé Jouanolle France 10 359 1.1× 428 1.4× 316 1.4× 247 1.2× 255 1.5× 18 838
S. Fargion Italy 7 211 0.6× 253 0.8× 191 0.8× 71 0.4× 136 0.8× 12 480
Kristina Tortorelli United States 7 364 1.1× 186 0.6× 117 0.5× 202 1.0× 79 0.5× 9 663
Dario Tavazzi Italy 14 164 0.5× 257 0.8× 272 1.2× 54 0.3× 77 0.5× 36 718
Anna Vergani Italy 13 159 0.5× 744 2.4× 580 2.5× 80 0.4× 462 2.8× 13 957
Elizabeth Klein United States 9 146 0.4× 276 0.9× 152 0.6× 34 0.2× 126 0.8× 32 510
Nick Wlazlo Netherlands 8 155 0.5× 112 0.4× 71 0.3× 55 0.3× 39 0.2× 14 363
Laurence Britton Australia 10 162 0.5× 79 0.3× 50 0.2× 101 0.5× 40 0.2× 20 327
S Distante Norway 11 55 0.2× 256 0.8× 197 0.8× 62 0.3× 184 1.1× 24 446
James D. Perkins United States 9 90 0.3× 63 0.2× 53 0.2× 162 0.8× 47 0.3× 21 413

Countries citing papers authored by D. Guyader

Since Specialization
Citations

This map shows the geographic impact of D. Guyader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Guyader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Guyader more than expected).

Fields of papers citing papers by D. Guyader

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Guyader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Guyader. The network helps show where D. Guyader may publish in the future.

Co-authorship network of co-authors of D. Guyader

This figure shows the co-authorship network connecting the top 25 collaborators of D. Guyader. A scholar is included among the top collaborators of D. Guyader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Guyader. D. Guyader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Berliba, Elina, Tengiz Tsertsvadze, D. Guyader, et al.. (2016). AL-335, a Once-Daily Pangenotypic Nucleotide HCV Polymerase Inhibitor, Demonstrates Potent Antiviral Activity over 7 Days in Treatment-Naïve Genotype 1-4 Patients. Journal of Hepatology. 64(2). S404–S405. 3 indexed citations
3.
Zoulim, Fabien, Xavier Causse, Dominique Larrey, et al.. (2014). P1061 LONG-TERM TREATMENT WITH TENOFOVIR IN TREATMENT-NAIVE OR -EXPERIENCED CHB PATIENTS IS EFFECTIVE AND WELL TOLERATED IN REAL-LIFE PRACTICE: 3 YEARS RESULTS OF THE VIREAL STUDY. Journal of Hepatology. 60(1). S430–S430. 4 indexed citations
4.
Hézode, C., Xavier Causse, Dominique Larrey, et al.. (2013). 748 VIROLOGICAL RESPONSE AND TOLERANCE OF TENOFOVIR DF (TDF) IN THE ELDERLY IS SIMILAR TO YOUNGER PATIENTS IN REAL LIFE PRACTICE. Journal of Hepatology. 58. S303–S303. 4 indexed citations
5.
6.
Guyader, D., Pavel Bogomolov, Zhanna Kobalava, et al.. (2011). 1209 IMO-2125 PLUS RIBAVIRIN GIVES SUBSTANTIAL FIRST-DOSE VIRAL LOAD REDUCTIONS, CUMULATIVE ANTI-VIRAL EFFECT, IS WELL TOLERATED IN NAIVE GENOTYPE1 HCV PATIENTS: A PHASE 1 TRIAL. Journal of Hepatology. 54. S478–S478. 4 indexed citations
7.
Forestier, Nicole, Dominique Larrey, Patrick Marcellin, et al.. (2009). 85 ANTIVIRAL ACTIVITY AND SAFETY OF ITMN-191 IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV). Journal of Hepatology. 50. S35–S35. 15 indexed citations
8.
Roudot‐Thoraval, Françoise, Denis Ouzan, Jacques Denis, et al.. (2008). 833 LIVER FIBROSIS ASSESSMENT IN CHRONIC HEPATITIS C: EVOLUTION OF CLINICAL PRACTICE IN A LARGE COHORT OF 4546 PATIENTS BETWEEN 2003 AND 2006. Journal of Hepatology. 48. S312–S312. 1 indexed citations
9.
Boucher, Éveline, V. Canva, Bruno Turlin, et al.. (2001). High rate lond term response after one year interferon (IFN) plus ribavirine treatment for hepatitis C relapsers. Results of a controlled randomized study in 191 patients. Journal of Hepatology. 34. 167–167. 2 indexed citations
10.
Brissot, Pierre, D. Guyader, Olivier Loréal, et al.. (2000). Clinical aspects of hemochromatosis. Transfusion Science. 23(3). 193–200. 31 indexed citations
11.
Calès, Paul, Frédéric Oberti, Jean‐Louis Payen, et al.. (1999). Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis. European Journal of Gastroenterology & Hepatology. 11(7). 741–741. 95 indexed citations
12.
Mendler, Michel-Henry, Bruno Turlin, Romain Moirand, et al.. (1999). Insulin resistance–associated hepatic iron overload. Gastroenterology. 117(5). 1155–1163. 377 indexed citations
13.
Loréal, Olivier, Romain Moirand, D. Guyader, et al.. (1992). Liver fibrosis in genetic hemochromatosis. Journal of Hepatology. 16(1-2). 122–127. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hervé Jouanolle Breakdown of academic impact, for papers by S. Fargion Breakdown of academic impact, for papers by Kristina Tortorelli Breakdown of academic impact, for papers by Dario Tavazzi Breakdown of academic impact, for papers by Anna Vergani Breakdown of academic impact, for papers by Elizabeth Klein Breakdown of academic impact, for papers by Nick Wlazlo Breakdown of academic impact, for papers by Laurence Britton Breakdown of academic impact, for papers by S Distante Breakdown of academic impact, for papers by James D. Perkins
Rankless by CCL
2026